# Detect Inc. receives $8.1M NIH contract for Covid-19 test manufacturing

Detect Inc. announced that the NIH selected its Detect Covid-19 Test to receive $8.1 million in funding from the RADx initiative to facilitate development and scale up manufacturing of its PCR-quality rapid at-home Covid-19 test.

- Type: Contract
- Announced: 2021-10-14
- Where: Guilford, Connecticut, United States
- Value: $8.10M
- Status: announced
- Products: Detect Covid-19 Test, PCR-quality rapid at-home test
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Detect Inc.](https://endata.com/companies/58429.md)
- [National Institutes of Health](https://endata.com/companies/48424.md) (customer)

## Sources

- [biospace.com](https://www.biospace.com/detect-selected-by-nih-to-scale-manufacturing-of-pcr-quality-rapid-at-home-covid-19-test), 2021-10-14: "The $8.1 million contract will facilitate the development and scale up manufacturing of Detect's PCR-quality rapid at-home Covid-19 test to meet national testing demand."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.